225 related articles for article (PubMed ID: 16202823)
21. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
[TBL] [Abstract][Full Text] [Related]
22. [Apheresis therapy in Guillain-Barré syndrome].
Nagayama H; Katayama Y
Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
[TBL] [Abstract][Full Text] [Related]
23. Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis.
Cheng BC; Chang WN; Chen JB; Chee EC; Huang CR; Lu CH; Chang CJ; Hung PL; Chuang YC; Lee CT; Lee PY; Wang KW; Chang HW
J Clin Apher; 2003; 18(4):175-80. PubMed ID: 14699593
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation.
Netto AB; Taly AB; Kulkarni GB; Uma Maheshwara Rao GS; Rao S
Neurol India; 2011; 59(5):707-11. PubMed ID: 22019655
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of anti-glycolipid antibody-associated neuropathy].
Yuki N
Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
Alshekhlee A; Hussain Z; Sultan B; Katirji B
J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
[TBL] [Abstract][Full Text] [Related]
27. [Guillain-Barré syndrome].
Raphaël JC
Rev Prat; 2005 Apr; 55(8):823-7. PubMed ID: 15999835
[TBL] [Abstract][Full Text] [Related]
28. Guillain-Barré syndrome--a patient guide and nursing resource.
Kehoe M
Axone; 2001 Jun; 22(4):16-24. PubMed ID: 14621501
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
[TBL] [Abstract][Full Text] [Related]
30. Clinical presentation and prognosis of childhood Guillain-Barré syndrome.
Lee JH; Sung IY; Rew IS
J Paediatr Child Health; 2008; 44(7-8):449-54. PubMed ID: 18557809
[TBL] [Abstract][Full Text] [Related]
31. Motor recovery after Guillain-Barré syndrome in childhood.
Ortiz-Corredor F; Peña-Preciado M; Díaz-Ruíz J
Disabil Rehabil; 2007 Jun 15-30; 29(11-12):883-9. PubMed ID: 17577723
[TBL] [Abstract][Full Text] [Related]
32. Hospital admissions for Guillain-Barré syndrome in the United States, 1993-2004.
Frenzen PD
Neuroepidemiology; 2007; 29(1-2):83-8. PubMed ID: 17925599
[TBL] [Abstract][Full Text] [Related]
33. [Present treatment of Guillain-Barre syndrome].
Raphaël JC
Bull Acad Natl Med; 2004; 188(1):87-94; discussion 94-5. PubMed ID: 15368928
[TBL] [Abstract][Full Text] [Related]
34. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
Tsai CP; Wang KC; Liu CY; Sheng WY; Lee TC
J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
[TBL] [Abstract][Full Text] [Related]
35. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350
[TBL] [Abstract][Full Text] [Related]
36. [High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome].
Lüke C; Dohmen C; Dietlein TS; Brunner R; Lüke M; Krieglstein GK
Klin Monbl Augenheilkd; 2007 Dec; 224(12):932-4. PubMed ID: 18260057
[TBL] [Abstract][Full Text] [Related]
37. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
Kuwabara S; Nakajima M; Moroo I; Hirayama K
Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
[TBL] [Abstract][Full Text] [Related]
38. Guillain-Barré syndrome and hemophagocytic lymphohistiocytosis in a patient with severe chronic active Epstein-Barr virus infection syndrome.
Takahashi K; Kunishige M; Shinohara M; Kubo K; Inoue H; Yoshino H; Asano A; Honda S; Matsumoto T; Mitsui T
Clin Neurol Neurosurg; 2005 Dec; 108(1):80-3. PubMed ID: 16311154
[TBL] [Abstract][Full Text] [Related]
39. [Guillain-Barre syndrome: etiology and pathogenesis].
Avila-Funes JA; Mariona-Montero VA; Melano-Carranza E
Rev Invest Clin; 2002; 54(4):357-63. PubMed ID: 12415961
[TBL] [Abstract][Full Text] [Related]
40. [Guillain-Barre syndrome and IVIg: does early initiation of treatment influence the mean hospital stay?].
Coll-Cantí J; Alvarez-Ramo R; Dorado L; Guerrero C; Serichol M; Dávalos A; Martínez EM
Neurologia; 2009 May; 24(4):217-9. PubMed ID: 19603290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
